Navigation Links
Wounded Warriors a Focus of the 12th New Jersey Symposium on Biomaterials Science
Date:8/1/2014

Piscataway, NJ (PRWEB) August 02, 2014

For the past five years, the New Jersey Center for Biomaterials under the auspices of the Armed Forces Institute of Regenerative Medicine (AFIRM) has led a consortium of academic research organizations in the development of advanced treatment options for our severely wounded warriors. AFIRM is a multi-institutional, inter¬disciplinary network working to develop new products and therapies to treat severe injuries suffered by US servicemen and women in the current wars. The AFIRM teams, working in research laboratories and clinics across the country, are advancing biological therapies (including adult stem cells and growth factors), tissue and biomaterials engineering, and advanced transplantation methods. These new treatments will enable the body to repair, replace, restore and regenerate damaged tissues and organs.

The 12th New Jersey Symposium on Biomaterials Science will focus several presentations on the regeneration of nerves and muscle resulting from catastrophic peripheral nerve injury and muscular tissue loss for Wounded Warriors. These types of injuries to the body’s soft tissue are leading sources of lifelong disability. Extreme trauma from combat wounds can cause nerve injuries that create gaps in the nerves leading to the muscles of the limbs. The success in this work for our Wounded Warriors is readily translatable to injuries suffered by the civilian population resulting from industrial and automobile accidents.

Registration for the 12th NJ Symposium on Biomaterials Science is available at http://www.njbiomaterials.org/biomaterials-symposia.htm.

The New Jersey Center for Biomaterials (NJCBM) was founded in 1997. Based at Rutgers, the State University of New Jersey, the center spans academia, industry, and government. Staffed by biomaterial scientists, the Center works to improve health care and quality of life by developing advanced biomedical products for tissue repair and replacement as well as the delivery of pharmaceutical agents. The Center’s technologies have been translated into clinical and pre-clinical products including surgical meshes, cardiovascular stents, bone regeneration scaffolds, and ocular drug delivery systems.

Media Contact:

Louli Kourkounakis
(732) 445 0488 ext. 40001
symposium(at)dls(dot)rutgers(dot)edu

Read the full story at http://www.prweb.com/releases/2014/08/prweb12062870.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Arteriocyte Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors
2. Model Aviation Clubs Raise $76,000 for the Wounded Warrior Project
3. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
4. Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient Response
5. Receptos and Ono Establish Collaboration with Focus on Bioactive Lipid Discovery Research
6. Access BridgeGap Ventures to Focus on Early-Stage Therapeutic Opportunities
7. Vermillion Sharpens Focus and Streamlines Operations in 2012
8. Inverseon Focuses on Mucous and Smoking Cessation
9. First Statewide Biotech Meeting Focuses on Patient Access, Innovation
10. Global Markets for Enzymes in Industrial Applications -- Focus on Europe
11. QuantRx® Biomedical Provides Corporate Update: Focused on Diagnostics and Feminine Hygiene Segments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... NC (PRWEB) , ... June 24, 2016 , ... Researchers ... the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are ... to read it now. , Diagnostic biomarkers are signposts in the blood, lung ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking ... Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity as ...
Breaking Biology Technology:
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):